社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
i港股
微信公众号:i港股网 www.iHKSTOCK.COM
IP属地:广东
+关注
帖子 · 50
帖子 · 50
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
i港股
i港股
·
2020-12-15
IPO快讯 | 瑞丽医美(02135.HK)今起招股
瑞丽医美(02135.HK)今起招股。全球发售3.425亿股股份,其中公开发售股份3425万股,国际发售股份约3.08亿股,另有15%超额配股权;2020年12月15日至12月18日招股,中签公布日为2020年12月24日;发售价每股发售股份0.30港元-0.40港元,每手股份数量10000股,入场费约4040.3港元,预期于2020年12月28日联交所主板上市。 图片来源: i港股网 iHkstock.com1公司简介瑞丽医美$瑞丽医美(02135.HK)$成立于2008年,是一家医疗美容服务供应商。主要提供的美容外科服务、微创美容服务和皮肤美容服务三大类的服务。公司所有的医疗美容机构均以“瑞丽”、“瑞丽整形”以及“Raily”营运。根据弗若斯特沙利文报告,按2019年医疗美容服务收益计,集团在杭州市及浙江省所占市场份额约为4.1%及1.9%,在所有私营医疗美容服务提供商当中分别名列第四及第五位。2行业概况2024年,中国美容非外科诊疗市场预计将达到1443亿元人民币,占市场总额约45.3%。随着医疗美容服务认知度及渗透率提高,庞大的人口将给市场带来红利。添加图片描述根据弗若斯特沙利文报告,2015年至2019年,中国医疗美容服务人均开支从人民币46元增至人民币103元,未来5年,考虑到美容服务需求及购买力不断增长,中国医疗美容服务人均开支预计将于2024年达到人民币223元。3公司业务瑞丽医美,2008年8月成立于杭州,是一家医疗美容服务供应商,拥有四家私人医疗美容机构,三家位于浙江,一家位于安徽。主要提供美容外科服务、微创美容服务和皮肤美容服务三大类的服务。添加图片描述4财务资料2017年、2018年、2019年及2020年上半年,瑞丽医美实现营业收入1.13亿、1.59亿、1.91亿、5873万元人民币,对应净利润分别为1740.5万、1841.8万元、1027.7
看
7,214
回复
评论
点赞
2
编组 21备份 2
分享
举报
IPO快讯 | 瑞丽医美(02135.HK)今起招股
i港股
i港股
·
2022-06-28
今晚赌场$Agile Therapeutics(AGRX.US)$
看
2,090
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-28
$Agile Therapeutics, Inc.(AGRX)$
今晚10块见
看
4,538
回复
2
点赞
6
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-28
$Evofem Biosciences Inc.(EVFM)$
$Evofem Biosciences(EVFM.US)$ 转$Agile Therapeutics(AGRX.US)$
看
2,641
回复
评论
点赞
3
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-28
$Femasys Inc(FEMY)$
我已做好溶断准备
看
3,504
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-28
$Femasys Inc(FEMY)$
要溶断了
看
3,201
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-28
$Femasys Inc(FEMY)$
$Boxed Inc(BOXD)$
$Boxed Inc(BOXD)$
$Boxed Inc(BOXD)$
起飞了
看
3,430
回复
1
点赞
2
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-24
$蓝帽子(BHAT)$
再不拉我转场了
看
2,852
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-24
$蓝帽子(BHAT)$
转场
$天地荟食品(PETZ)$
看
3,910
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-24
$蓝帽子(BHAT)$
$露华浓(REV)$
$知乎(ZH)$
收到风gme2.0外国讨论区
看
5,724
回复
2
点赞
2
编组 21备份 2
分享
举报
i港股
i港股
·
2022-06-17
$露华浓(REV)$
冲5保4
看
2,170
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3461234859175834","uuid":"3461234859175834","gmtCreate":1498201715444,"gmtModify":1607058811000,"name":"i港股","pinyin":"iggiganggu","introduction":"","introductionEn":"","signature":"微信公众号:i港股网 \nwww.iHKSTOCK.COM","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":427,"headSize":16,"tweetSize":50,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":9,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":394637832,"gmtCreate":1608018001226,"gmtModify":1703850626791,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"title":"IPO快讯 | 瑞丽医美(02135.HK)今起招股","htmlText":"瑞丽医美(02135.HK)今起招股。全球发售3.425亿股股份,其中公开发售股份3425万股,国际发售股份约3.08亿股,另有15%超额配股权;2020年12月15日至12月18日招股,中签公布日为2020年12月24日;发售价每股发售股份0.30港元-0.40港元,每手股份数量10000股,入场费约4040.3港元,预期于2020年12月28日联交所主板上市。 图片来源: i港股网 iHkstock.com1公司简介瑞丽医美$瑞丽医美(02135.HK)$成立于2008年,是一家医疗美容服务供应商。主要提供的美容外科服务、微创美容服务和皮肤美容服务三大类的服务。公司所有的医疗美容机构均以“瑞丽”、“瑞丽整形”以及“Raily”营运。根据弗若斯特沙利文报告,按2019年医疗美容服务收益计,集团在杭州市及浙江省所占市场份额约为4.1%及1.9%,在所有私营医疗美容服务提供商当中分别名列第四及第五位。2行业概况2024年,中国美容非外科诊疗市场预计将达到1443亿元人民币,占市场总额约45.3%。随着医疗美容服务认知度及渗透率提高,庞大的人口将给市场带来红利。添加图片描述根据弗若斯特沙利文报告,2015年至2019年,中国医疗美容服务人均开支从人民币46元增至人民币103元,未来5年,考虑到美容服务需求及购买力不断增长,中国医疗美容服务人均开支预计将于2024年达到人民币223元。3公司业务瑞丽医美,2008年8月成立于杭州,是一家医疗美容服务供应商,拥有四家私人医疗美容机构,三家位于浙江,一家位于安徽。主要提供美容外科服务、微创美容服务和皮肤美容服务三大类的服务。添加图片描述4财务资料2017年、2018年、2019年及2020年上半年,瑞丽医美实现营业收入1.13亿、1.59亿、1.91亿、5873万元人民币,对应净利润分别为1740.5万、1841.8万元、1027.7","listText":"瑞丽医美(02135.HK)今起招股。全球发售3.425亿股股份,其中公开发售股份3425万股,国际发售股份约3.08亿股,另有15%超额配股权;2020年12月15日至12月18日招股,中签公布日为2020年12月24日;发售价每股发售股份0.30港元-0.40港元,每手股份数量10000股,入场费约4040.3港元,预期于2020年12月28日联交所主板上市。 图片来源: i港股网 iHkstock.com1公司简介瑞丽医美$瑞丽医美(02135.HK)$成立于2008年,是一家医疗美容服务供应商。主要提供的美容外科服务、微创美容服务和皮肤美容服务三大类的服务。公司所有的医疗美容机构均以“瑞丽”、“瑞丽整形”以及“Raily”营运。根据弗若斯特沙利文报告,按2019年医疗美容服务收益计,集团在杭州市及浙江省所占市场份额约为4.1%及1.9%,在所有私营医疗美容服务提供商当中分别名列第四及第五位。2行业概况2024年,中国美容非外科诊疗市场预计将达到1443亿元人民币,占市场总额约45.3%。随着医疗美容服务认知度及渗透率提高,庞大的人口将给市场带来红利。添加图片描述根据弗若斯特沙利文报告,2015年至2019年,中国医疗美容服务人均开支从人民币46元增至人民币103元,未来5年,考虑到美容服务需求及购买力不断增长,中国医疗美容服务人均开支预计将于2024年达到人民币223元。3公司业务瑞丽医美,2008年8月成立于杭州,是一家医疗美容服务供应商,拥有四家私人医疗美容机构,三家位于浙江,一家位于安徽。主要提供美容外科服务、微创美容服务和皮肤美容服务三大类的服务。添加图片描述4财务资料2017年、2018年、2019年及2020年上半年,瑞丽医美实现营业收入1.13亿、1.59亿、1.91亿、5873万元人民币,对应净利润分别为1740.5万、1841.8万元、1027.7","text":"瑞丽医美(02135.HK)今起招股。全球发售3.425亿股股份,其中公开发售股份3425万股,国际发售股份约3.08亿股,另有15%超额配股权;2020年12月15日至12月18日招股,中签公布日为2020年12月24日;发售价每股发售股份0.30港元-0.40港元,每手股份数量10000股,入场费约4040.3港元,预期于2020年12月28日联交所主板上市。 图片来源: i港股网 iHkstock.com1公司简介瑞丽医美$瑞丽医美(02135.HK)$成立于2008年,是一家医疗美容服务供应商。主要提供的美容外科服务、微创美容服务和皮肤美容服务三大类的服务。公司所有的医疗美容机构均以“瑞丽”、“瑞丽整形”以及“Raily”营运。根据弗若斯特沙利文报告,按2019年医疗美容服务收益计,集团在杭州市及浙江省所占市场份额约为4.1%及1.9%,在所有私营医疗美容服务提供商当中分别名列第四及第五位。2行业概况2024年,中国美容非外科诊疗市场预计将达到1443亿元人民币,占市场总额约45.3%。随着医疗美容服务认知度及渗透率提高,庞大的人口将给市场带来红利。添加图片描述根据弗若斯特沙利文报告,2015年至2019年,中国医疗美容服务人均开支从人民币46元增至人民币103元,未来5年,考虑到美容服务需求及购买力不断增长,中国医疗美容服务人均开支预计将于2024年达到人民币223元。3公司业务瑞丽医美,2008年8月成立于杭州,是一家医疗美容服务供应商,拥有四家私人医疗美容机构,三家位于浙江,一家位于安徽。主要提供美容外科服务、微创美容服务和皮肤美容服务三大类的服务。添加图片描述4财务资料2017年、2018年、2019年及2020年上半年,瑞丽医美实现营业收入1.13亿、1.59亿、1.91亿、5873万元人民币,对应净利润分别为1740.5万、1841.8万元、1027.7","images":[{"img":"https://static.tigerbbs.com/ffcef9c5c6d5baa7eed3d60e003a8d74","width":"688","height":"1494"},{"img":"https://static.tigerbbs.com/883b62d04553f9b122460ff2295edce8","width":"688","height":"518"},{"img":"https://static.tigerbbs.com/7a14ef8fb6f4ca1d553d22a8c2c0f85d","width":"688","height":"224"}],"top":2,"highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/394637832","isVote":1,"tweetType":1,"viewCount":7214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":7,"langContent":"CN","totalScore":0},{"id":683545800,"gmtCreate":1656428871201,"gmtModify":1704864784544,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"今晚赌场$Agile Therapeutics(AGRX.US)$","listText":"今晚赌场$Agile Therapeutics(AGRX.US)$","text":"今晚赌场$Agile Therapeutics(AGRX.US)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/683545800","isVote":1,"tweetType":1,"viewCount":2090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683515014,"gmtCreate":1656407008542,"gmtModify":1704864698205,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGRX\">$Agile Therapeutics, Inc.(AGRX)$</a>今晚10块见","listText":"<a href=\"https://laohu8.com/S/AGRX\">$Agile Therapeutics, Inc.(AGRX)$</a>今晚10块见","text":"$Agile Therapeutics, Inc.(AGRX)$今晚10块见","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/683515014","isVote":1,"tweetType":1,"viewCount":4538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683516365,"gmtCreate":1656406192158,"gmtModify":1704864695111,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EVFM\">$Evofem Biosciences Inc.(EVFM)$</a>$Evofem Biosciences(EVFM.US)$ 转$Agile Therapeutics(AGRX.US)$","listText":"<a href=\"https://laohu8.com/S/EVFM\">$Evofem Biosciences Inc.(EVFM)$</a>$Evofem Biosciences(EVFM.US)$ 转$Agile Therapeutics(AGRX.US)$","text":"$Evofem Biosciences Inc.(EVFM)$$Evofem Biosciences(EVFM.US)$ 转$Agile Therapeutics(AGRX.US)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/683516365","isVote":1,"tweetType":1,"viewCount":2641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683217884,"gmtCreate":1656348641752,"gmtModify":1704864530620,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FEMY\">$Femasys Inc(FEMY)$</a>我已做好溶断准备","listText":"<a href=\"https://laohu8.com/S/FEMY\">$Femasys Inc(FEMY)$</a>我已做好溶断准备","text":"$Femasys Inc(FEMY)$我已做好溶断准备","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/683217884","isVote":1,"tweetType":1,"viewCount":3504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683214384,"gmtCreate":1656348134451,"gmtModify":1704864528560,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FEMY\">$Femasys Inc(FEMY)$</a>要溶断了","listText":"<a href=\"https://laohu8.com/S/FEMY\">$Femasys Inc(FEMY)$</a>要溶断了","text":"$Femasys Inc(FEMY)$要溶断了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/683214384","isVote":1,"tweetType":1,"viewCount":3201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683214914,"gmtCreate":1656348001843,"gmtModify":1704864528390,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FEMY\">$Femasys Inc(FEMY)$</a> <a href=\"https://laohu8.com/S/BOXD\">$Boxed Inc(BOXD)$</a> <a href=\"https://laohu8.com/S/BOXD\">$Boxed Inc(BOXD)$</a> <a href=\"https://laohu8.com/S/BOXD\">$Boxed Inc(BOXD)$</a>起飞了","listText":"<a href=\"https://laohu8.com/S/FEMY\">$Femasys Inc(FEMY)$</a> <a href=\"https://laohu8.com/S/BOXD\">$Boxed Inc(BOXD)$</a> <a href=\"https://laohu8.com/S/BOXD\">$Boxed Inc(BOXD)$</a> <a href=\"https://laohu8.com/S/BOXD\">$Boxed Inc(BOXD)$</a>起飞了","text":"$Femasys Inc(FEMY)$ $Boxed Inc(BOXD)$ $Boxed Inc(BOXD)$ $Boxed Inc(BOXD)$起飞了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/683214914","isVote":1,"tweetType":1,"viewCount":3430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683162376,"gmtCreate":1656067825698,"gmtModify":1704864041355,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BHAT\">$蓝帽子(BHAT)$</a>再不拉我转场了","listText":"<a href=\"https://laohu8.com/S/BHAT\">$蓝帽子(BHAT)$</a>再不拉我转场了","text":"$蓝帽子(BHAT)$再不拉我转场了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/683162376","isVote":1,"tweetType":1,"viewCount":2852,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683363911,"gmtCreate":1656005266435,"gmtModify":1704863864470,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BHAT\">$蓝帽子(BHAT)$</a>转场<a href=\"https://laohu8.com/S/PETZ\">$天地荟食品(PETZ)$</a>","listText":"<a href=\"https://laohu8.com/S/BHAT\">$蓝帽子(BHAT)$</a>转场<a href=\"https://laohu8.com/S/PETZ\">$天地荟食品(PETZ)$</a>","text":"$蓝帽子(BHAT)$转场$天地荟食品(PETZ)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/683363911","isVote":1,"tweetType":1,"viewCount":3910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":683384377,"gmtCreate":1656002397101,"gmtModify":1704863857918,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BHAT\">$蓝帽子(BHAT)$</a> <a href=\"https://laohu8.com/S/REV\">$露华浓(REV)$</a> <a href=\"https://laohu8.com/S/ZH\">$知乎(ZH)$</a>收到风gme2.0外国讨论区","listText":"<a href=\"https://laohu8.com/S/BHAT\">$蓝帽子(BHAT)$</a> <a href=\"https://laohu8.com/S/REV\">$露华浓(REV)$</a> <a href=\"https://laohu8.com/S/ZH\">$知乎(ZH)$</a>收到风gme2.0外国讨论区","text":"$蓝帽子(BHAT)$ $露华浓(REV)$ $知乎(ZH)$收到风gme2.0外国讨论区","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/683384377","isVote":1,"tweetType":1,"viewCount":5724,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":689848743,"gmtCreate":1655479480184,"gmtModify":1704862553765,"author":{"id":"3461234859175834","authorId":"3461234859175834","name":"i港股","avatar":"https://static.tigerbbs.com/8f06a5cea786d3855ca36f79976677a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461234859175834","authorIdStr":"3461234859175834"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/REV\">$露华浓(REV)$</a>冲5保4","listText":"<a href=\"https://laohu8.com/S/REV\">$露华浓(REV)$</a>冲5保4","text":"$露华浓(REV)$冲5保4","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/689848743","isVote":1,"tweetType":1,"viewCount":2170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}